GSK plc (GLAXF)
USD 16.84
(0.0%)
USD 16.84
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 30.32 Billion | 29.32 Billion | 34.11 Billion | 34.09 Billion | 33.75 Billion | 30.82 Billion |
| Cost of Revenue | 9.07 Billion | 9.55 Billion | 11.6 Billion | 11.7 Billion | 11.86 Billion | 10.24 Billion |
| Gross Profit | 21.25 Billion | 19.77 Billion | 22.51 Billion | 22.39 Billion | 21.89 Billion | 20.58 Billion |
| Operating Expenses | 15.01 Billion | 13.33 Billion | 16.31 Billion | 14.61 Billion | 14.93 Billion | 15.09 Billion |
| Selling, General and Administrative Expenses | 9.38 Billion | 8.37 Billion | 10.97 Billion | 11.45 Billion | 11.4 Billion | 9.91 Billion |
| Research and Development Expenses | 6.22 Billion | 5.48 Billion | 5.27 Billion | 5.09 Billion | 4.56 Billion | 3.89 Billion |
| Other Expenses | -590 Million | - | - | - | - | - |
| Cost and Expenses | 23.58 Billion | 22.89 Billion | 27.91 Billion | 26.31 Billion | 26.79 Billion | 25.33 Billion |
| Operating Income | 6.74 Billion | 6.43 Billion | 6.2 Billion | 7.78 Billion | 6.96 Billion | 5.48 Billion |
| Interest Expense | 775 Million | 879 Million | 784 Million | 892 Million | 912 Million | 798 Million |
| Income Tax Expense | 756 Million | 707 Million | 346 Million | 580 Million | 953 Million | 754 Million |
| Earnings before Tax | 6.06 Billion | 5.62 Billion | 5.44 Billion | 6.96 Billion | 6.22 Billion | 4.8 Billion |
| Net Income | 4.92 Billion | 14.95 Billion | 4.38 Billion | 5.74 Billion | 4.64 Billion | 3.62 Billion |
| Earnings Per Share Basic | 1.20 | 3.71 | 1.37 | 1.44 | 1.17 | 0.92 |
| Earnings Per Share Diluted | 1.20 | 3.66 | 1.35 | 1.43 | 1.16 | 0.91 |
| Weighted Average Shares Outstanding | 4.11 Billion | 4.02 Billion | 3.2 Billion | 3.98 Billion | 3.95 Billion | 3.93 Billion |
| Weighted Average Shares Outstanding (Diluted) | 4.11 Billion | 4.08 Billion | 3.24 Billion | 4.03 Billion | 4.01 Billion | 3.97 Billion |
| Gross Margin | 0.70 | 0.67 | 0.66 | 0.66 | 0.65 | 0.67 |
| EBIT Margin | 0.30 | 0.30 | 0.26 | 0.25 | 0.30 | 0.24 |
| Profit Margin | 0.16 | 0.51 | 0.13 | 0.17 | 0.14 | 0.12 |
| EBITDA | 9.08 Billion | 8.6 Billion | 6.48 Billion | 8.06 Billion | 10.12 Billion | 7.35 Billion |
| Earnings Before Tax Margin | 0.22 | 0.22 | 0.18 | 0.23 | 0.21 | 0.18 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 8.01 Billion | 7.88 Billion | 7.36 Billion | 30.32 Billion | 8.05 Billion | 8.14 Billion |
| Cost of Revenue | 2.39 Billion | 2.08 Billion | 1.93 Billion | 9.07 Billion | 2.33 Billion | 2.27 Billion |
| Gross Profit | 5.61 Billion | 5.8 Billion | 5.42 Billion | 21.25 Billion | 5.71 Billion | 5.87 Billion |
| Operating Expenses | 5.42 Billion | 3.81 Billion | 3.44 Billion | 14.25 Billion | 4.66 Billion | 3.92 Billion |
| Selling, General and Administrative Expenses | 3.8 Billion | 2.39 Billion | 2.07 Billion | - | 2.61 Billion | 2.29 Billion |
| Research and Development Expenses | 1.45 Billion | 1.42 Billion | 1.37 Billion | - | 2.04 Billion | 1.57 Billion |
| Other Expenses | 167 Million | 174 Million | - | - | - | - |
| Cost and Expenses | 7.82 Billion | 5.89 Billion | 5.38 Billion | 23.33 Billion | 7 Billion | 6.19 Billion |
| Operating Income | 189 Million | 1.98 Billion | 1.98 Billion | 6.99 Billion | 1.05 Billion | 1.94 Billion |
| Interest Expense | 156 Million | 174 Million | 166 Million | 775 Million | 222 Million | 182 Million |
| Income Tax Expense | -1 Million | 191 Million | 274 Million | 756 Million | -19 Million | 257 Million |
| Earnings before Tax | 64 Million | 1.49 Billion | 1.35 Billion | 6.06 Billion | 380 Million | 1.79 Billion |
| Net Income | -58 Million | 1.17 Billion | 1.04 Billion | 4.92 Billion | 350 Million | 1.46 Billion |
| Earnings Per Share Basic | -0.01 | 0.29 | 0.26 | - | 0.09 | 0.36 |
| Earnings Per Share Diluted | -0.01 | 0.28 | 0.25 | - | 0.08 | 0.36 |
| Weighted Average Shares Outstanding | 4.08 Billion | 4.07 Billion | 4.06 Billion | 4.05 Billion | 4.05 Billion | 4.05 Billion |
| Weighted Average Shares Outstanding (Diluted) | 4.08 Billion | 4.12 Billion | 4.11 Billion | 4.11 Billion | 4.11 Billion | 4.11 Billion |
| Gross Margin | 0.70 | 0.74 | 0.74 | 0.70 | 0.71 | 0.72 |
| EBIT Margin | 0.15 | 0.33 | 0.34 | - | 0.28 | 0.31 |
| Profit Margin | -0.01 | 0.15 | 0.14 | 0.16 | 0.04 | 0.18 |
| EBITDA | 1.17 Billion | 2.62 Billion | 2.53 Billion | - | 2.23 Billion | 2.55 Billion |
| Earnings Before Tax Margin | 0.02 | 0.25 | 0.27 | 0.23 | 0.13 | 0.24 |
STSB
7636
FREVS
002321
QEBR
LVCLF